Prof. Tuuli Lappalainen, PhD, global leader in functional genomics, integrates large-scale human genetic and transcriptomic data with CRISPR-based perturbations. At the NYGC and the KTH she maps genetic effects on molecular traits to extract insights for human health. As Director of NGI, she is a key driver of genomics technology and applications strategy.

Assoc. Prof. Arutha Kulasinghe, PhD, internationally recognised pioneer in spatial biology, drives innovation across spatial genomics, transcriptomics, and proteomics. His research at the QSBC harnesses next-generation biotechnology to decode the molecular architecture of disease, delivering transformative insights into human biology and clinical care.

Asst. Prof. Christoph Ziegenhain, PhD, serial genomics innovator in single-cell sequencing, develops high-throughput molecular profiling tools. His group at the KI applies multi-omic technologies to discover new therapeutic targets. As CEO at Xpress Genomics, he is building cutting-edge sequencing and automation technologies to deliver NGS data at unprecedented scale.

Prof. Fan, PhD, a pioneer in single-cell and innovator in spatial transcriptomics, epigenomics and multi-omics sequencing, with major discoveries in brain development, inflammation, aging, senescence and immuno-oncology. At Yale, he leads the research on human spatial biomedicine, aiming to decode and engineering human biology for precision health and next generation therapeutics. 

Prof. Holger Heyn, PhD, genomics pioneer in single-cell, spatial and epigenomic sequencing, advances immune-based diagnostics and therapeutics. At CNAG he unites biotechnology and computational biology to decode the immune system. As CSO at Omniscope he delivers precision and interceptive medicine tools for health care.

Prof. Prabhakar, PhD, is an international leader in spatial and single-cell genomics, large-scale genomics, systems biology and machine learning. His team at A*STAR uses massive-scale data generation, algorithm development and data analytics for basic biology, diagnostics development and target discovery for cancers and immune disorders.

Prof. Joseph Powell is a global leader in population-scale genetics, single-cell genomics and AI-driven molecular discovery. At the Garvan Institute he builds and directs large-scale multi-omic and cell platforms that uncover causal biology and accelerate therapeutic development, while providing strategic guidance to biotech and venture groups.

Prof. Christopher Mason, PhD, has pioneered genomics technologies applied on astronauts and next-generation diagnostics. At Weill Cornell Medicine, his lab develops new biochemical and computational techniques in DNA/RNA sequencing and base modifications as well as genome engineering for new cells, genomes, and microbiomes.

Prof. Nick Banovich, PhD, is a leader in human genetics, specializing in single-cell and spatial multiomics technologies. At TGen, he is Vice President of Scientific Development and founding director of the Center for Spatial Multiomics (COSMO), studying genetic drivers of complex disease, especially of chronic lung disease together with large internal consortia.

Dr. Villani, a leader in genomics and systems immunology, leverages single-cell and spatial multi-omics to advance immune biomarker and therapeutic target discovery. At MGH, Harvard, and the Broad Institute, she integrates multi-omics and computation to define immune programs driving disease, improve disease classification, predict treatment response, and guide precision therapies.